Clinical Trial Update: Protective Effects of EPI-743 on Noise-Induced Hearing Loss [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the protective effects of EPI-743 on noise-induced hearing loss has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noise-induced Hearing Loss

Drugs mentioned

• EPI-743

Snippet

Sponsor: Edison Pharmaceuticals Inc | Conditions: Noise-induced Hearing Loss | Phase 2 | Status: COMPLETED